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Eff ects of inappropriate gas conditioning during 
non-invasive ventilation
Th e human airway has an important role in heating and 
humidifying inspired gas, and recovering heat and 
moisture from expired gas. Th e amount of water vapor in 
a gas mixture can be measured as absolute humidity 
(AH) or relative humidity (RH) in relation to the temp-
era ture. AH is the total water present in the gas (mg H2O/L) 
and RH is the amount of water present expressed as the 
percentage of maximum carrying capacity at a given 
temperature [1]. Th e human airway must provide gas at 
core temperature and 100% RH at the alveolar surface in 
order to optimize gas exchange and protect lung tissue 
[2].
Non-invasive ventilation (NIV) is a mechanical venti la-
tion modality that does not utilize an invasive artiﬁ cial 
airway (endotracheal tube or tracheostomy tube) [3]. 
NIV is usually delivered through a nasal or oro-nasal 
mask so the inspired gas passes through the upper airway 
where it is conditioned. Like during spontaneous breath-
ing, patients under NIV require adequate humidiﬁ cation 
and heating of the inspired air (that is, gas conditioning) 
[3]. NIV delivers inspired air at high ﬂ ow rates, which 
may overwhelm the usual airway humidiﬁ cation mecha-
nisms. Inadequate gas conditioning has been associated 
with anatomical and functional deterioration of nasal 
mucosa (ciliary activity, mucus secretion, local blood 
ﬂ ow, nasal resistance). In addition, there are also negative 
eﬀ ects on tolerance to NIV when a patient breathes 
inadequately humidiﬁ ed air [1,3-5] (Table 1).
Metaplastic changes and keratinization of the nasal 
epithelium and submucosa have been reported in patients 
on home-NIV when the level of humidiﬁ cation was 
inadequate for long periods [5]. Th ese histopathological 
ﬁ ndings were conﬁ rmed by our recent survey, which 
found similar structural changes of the nasal mucosa in 
four patients with acute respiratory failure treated for 
7 days with NIV without a humidiﬁ cation system added 
(unpublished data; Figure 1). Th is suggests that changes 
in the nasal mucosa occur relatively early after starting 
NIV in an acute setting and that humidiﬁ cation should be 
considered even when only short-term use of NIV is 
expected.
Inadequate airway gas conditioning may have serious 
consequences in critically ill patients using NIV [6,7]. 
Diﬃ  culties were recently reported with intubation in 
patients failing a trial of NIV delivered at high inspiratory 
oxygen fraction with a low level of humidiﬁ cation [6]. 
One case study showed ispissated secretions, causing 
life-threatening airway obstruction in a patient using 
NIV for hypoxemic respiratory failure [7]. A high fraction 
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of inspired oxygen was also entrained into the NIV circuit 
and this extra anhydrous gas may have contributed to the 
airway obstruction.
Inadequate humidiﬁ cation can also cause signiﬁ cant 
discomfort for chronic NIV users. In an experimental 
setting, Wiest and colleagues [8] showed that dryness-
related symptoms started to appear when AH was lower 
than 15  mgH2O/L. Normal subjects undergoing NIV 
without humidiﬁ cation scored discomfort signiﬁ cantly 
higher on a visual analogue scale than when heated 
humidiﬁ cation (HH) was used, and this was associated 
with increased nasal airway resistance (NAWR). HH 
improved comfort and compliance to NIV [6,9].
Similarly, Lellouche and colleagues [10], in healthy 
subjects under continuous positive airway pressure 
(CPAP) delivered by a bucco-nasal mask, found the level 
of comfort was signiﬁ cantly lower when no humidiﬁ  ca-
tion was used. When a humidiﬁ cation device was applied 
and AH was higher than 10 to 12 mgH2O/L comfort was 
signiﬁ cantly better [10].
In a very comprehensive compliance analysis in 
patients in home-NIV, Nava and colleagues [11] com-
pared two humidiﬁ cation systems, HH and a heat and 
moisture exchange ﬁ lter (HME); compliance was much 
better (75% of patients) with the former. However, other 
symptoms, such as dry throat, the number of hospital 
admissions and the rate of complications caused by 
infection (mainly pneumonia), were similar with the two 
systems [11]. Similar results were published by Massie 
and colleagues [12], who stressed the importance of 
‘early’ humidiﬁ cation from the very start of ventilatory 
treatment, so as to ensure the best possible compliance in 
home-NIV patients. Some other authors, however, 
maintain that humidiﬁ cation has no really signiﬁ cant 
eﬀ ect on adherence to chronic NIV [13].
Contributors to gas conditioning during 
non-invasive ventilation
Th e optimal hygrometric values of AH or RH in the 
diﬀ erent NIV applications have not yet been established, 
since most data come from experimental studies that 
took direct (nasal cavities) or indirect (thermometers) 
measurements [14]. However, analysis of the need for 
humidiﬁ cation during NIV must clearly take account of 
the following parameters: 1)  air leaks; 2)  interface for 
NIV delivery; 3) type of ventilator; 4) room temperature; 
5)  temperatures of inhaled gas and the vaporization 
chamber; 6)  airﬂ ow and pressure at the entrance of the 
humidiﬁ cation system; and 7)  type of humidiﬁ cation 
system.
Air leaks
Mouth and/or peripheral mask air leaks, especially in 
tachypneic patients under NIV, cause unidirectional 
nasal air ﬂ ow, so the mucosa recovers less heat and 
moisture during expiration. Th is may cause a continuous 
drop in AH. An increase in NAWR is the typical conse-
quence of large mouth air leaks during NIV from a nasal 
mask. Th is reﬂ ects the nasal vasoconstrictive response to 
prolonged inhalation of dry air [4,5]. Clinically, increased 
NAWR is likely to lead to unsuccessful acclimatization to 
NIV in the chronic setting, and to the failure of NIV to 
improve gas exchange and dyspnea in the acute setting. 
Air leaks will also aﬀ ect the performance of HMEs 
because the HME recovers less moisture when the 
expired air is drier.
Th e site of the leak, either unintentional (around the 
mask) or intentional (mask or circuit) also aﬀ ects 
humidity. While the unintentional leaks are likely to have 
a substantial impact on AH because of the compensatory 
increase in inspiratory ﬂ ow, the intentional leaks are not 
known to contribute to insuﬃ  cient humidiﬁ cation of air 
during NIV. We can only speculate that ineﬃ  cient wash-
out of the exhaled air throughout an unintentional leak 
system (that is, plateau valve, anti-rebreathing valve) is 
likely to involve a substantial degree of humidity, 
especially in interfaces with high dead space, such as a 
total face mask.
In a study in adult volunteers, nasal CPAP with a mouth 
leak resulted in a three-fold increase in NAWR that was 
substantially attenuated by eﬀ ective humidi ﬁ cation [15]. 
Table 1. Eff ects of ineffi  cient gas conditioning during 
non-invasive ventilation
Increased nasal airway resistance
Structural and functional damage to nasal mucosa
Increased work of breathing
Diffi  culty in intubation
Discomfort and poor compliance to non-invasive ventilation
Figure 1. Biopsy of nasal mucosa. Metaplasia (1) and keratinization 
(2) in nasal respiratory mucosa in one patient without humidifi cation 
during non-invasive ventilation.
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Th ese ﬁ ndings were conﬁ rmed in adult volunteers 
undergoing NIV [16]. Th is high NAWR would result in 
substantially lower eﬀ ective pressure being transmitted 
to the nasopharynx and subsequently to the distal airway 
(Figure 2).
Interfaces
Th e most common interfaces used to deliver NIV are 
nasal and facial masks, the former being tolerated better 
in the chronic than the acute setting. However, nasal 
masks tend to have more leaks than face masks, and this 
can result in inadequate gas conditioning of inspired air. 
Th e use of an oro-nasal mask avoids the changes in RH 
related to mouth leaks [17]. Th is choice is likely to be 
crucial to the success of NIV in selected categories of 
acute patients (for example, need for prolonged venti la-
tory support, diﬃ  culty in spontaneously clearing secre-
tions, mouth-breathers) [18,19].
Physicians using the helmet to deliver NIV must be 
particularly careful. Compared to the other more popular 
interfaces (nasal, oro-nasal, total face masks), the helmet 
has a much larger inner space (more than 10 liters), 
which may act as a ‘reservoir’ of humidity because of the 
amount of exhaled gas that remains there [19]. Th e 
clinician must therefore carefully adjust the humidiﬁ -
cation of the inhaled gas depending on the type of 
interface and the resulting leak pattern.
Ventilator types
Intensive care ventilators, home-care mechanical venti-
lators, and high-ﬂ ow CPAP systems operate by providing 
a very high inspiratory ﬂ ow to compensate for the 
inspira tory demand of a patient with acute respiratory 
failure and the air leaks when applied in a NIV mode. 
Th is issue was originally studied by Poulton and Downs 
[20] with high airﬂ ow CPAP systems delivered with a 
non-invasive interface.
Th e technical aspects are more sophisticated for the 
diﬀ erent NIV equipment introduced in the last few 
decades. Th e impact on humidiﬁ cation depends on the 
Figure 2. Pathophysiological eff ects of air leak on gas conditioning of the upper airways and its impact on nasal airway resistance and 
mucosa vasoconstriction.
1 U i t t i l k l k- n n ent onal mask leaks
1
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type of ventilator used in acute and chronic settings. 
Single-circuit home ventilators and/or dedicated NIV 
ventilators equipped with a turbine or piston diﬀ er from 
double-circuit ICU ventilators, which are pneumatic and 
supplied with high-pressure sources of gas. Home 
models - that is, blower-based devices - compress room 
air and have higher humidity than ICU ventilators, which 
obtain dry gas directly from a mains hospital outlet. Th is 
was clearly depicted by Wiest and colleagues [21], who 
demonstrated that ICU ventilators provided a lower level 
of AH during NIV than turbine mechanical ventilators (5 
versus 13 mgH2O/L) [21]. Here we have to bear in mind 
that AH lower than 5 mgH2O/L is ‘critical’ for the likeli-
hood of complications related to inadequate gas 
condition ing of inspired air [21].
Given the decrease in humidity resulting from the 
anhydrous nature of medical oxygen, physicians have also 
to remember that the higher the oxygen fraction 
delivered during NIV, the greater the risk of inadequate 
gas conditioning without the addition of HH or a HME.
Chiumello and colleagues [22] compared the hygro-
metric values in a helmet system during CPAP with or 
without HH, delivered by either a mechanical ventilator 
or a continuous low (40 L/minute) or high (80 L/minute) 
ﬂ ow CPAP, in nine patients with acute respiratory failure 
and ten healthy subjects. Th e HH system raised the AH 
during ventilator CPAP (from 18.4  ±  5.5  mgH2O/L to 
34.1  ±  2.8  mgH2O/L) and with CPAP at low ﬂ ow (from 
11.4  ±  4.8  mgH2O/L to 33.9  ±  1.9  mgH2O/L) and with 
CPAP at high ﬂ ow (from 6.4  ±  1.8  mgH2O/L to 
24.2  ±  5.4  mgH2O/L). Without HH, the AH was 
signiﬁ cantly higher with ventilator CPAP than with the 
continuous low ﬂ ow and high ﬂ ow. Th e level of comfort 
was similar for all three modalities, with or without the 
HH. Th e ﬁ ndings in healthy individuals were similar to 
those in patients with acute respiratory failure.
Ambient temperature
Even though insuﬃ  cient humidiﬁ cation during NIV can 
be caused by speciﬁ c climatic or environmental condi-
tions in the place where the treatment is implemented 
(for example, an excessively cold sleeping area), the 
majority of cases suﬀ ering from excessive airway dryness 
are due to technical factors related to the ventilation 
process itself and its interaction with the patient 
(interface, leaks, inspired oxygen fraction, respiratory 
rate, use of humidiﬁ ers). Th e eﬀ ects of ambient tempera-
ture probably only need be considered for patients who 
sleep in very cold premises.
Temperature of the inhaled gas
Conditioning inspired gas involves both heating and 
humidiﬁ cation. To facilitate gas exchange and protect 
lung tissue, inspired gas must reach body temperature by 
the time it arrives at the alveolar surface [23]. How easily 
this can be achieved depends on the temperature of the 
inhaled gas. Th e ventilator power source aﬀ ects gas 
temperature, as turbine-driven systems create more heat 
than piston-driven ventilators. Increasing levels of 
inspiratory positive airway pressure (IPAP) have also 
been reported to raise the gas temperature with a 
turbine-driven NIV device [24]. Th is tended to preserve 
AH at high IPAP levels, but it was not suﬃ  cient to 
maintain adequate humidity when ambient RH was low. 
In this bench study, HH set at its highest temperature 
was most eﬀ ective in countering the deleterious eﬀ ects of 
NIV on delivered humidity. In clinical practice the 
temperature setting for HH may be based on the patient’s 
tolerance.
Airfl ow at the entrance to the humidifi er
Th e impact of the airﬂ ow entering the HH humidiﬁ cation 
chamber is one of the most important physical pheno-
mena aﬀ ecting airway humidity. Th is was largely studied 
by Wenzel and colleagues [25], who analyzed the factors 
underlying humidiﬁ cation capacity over a variable range 
of airﬂ ows at the entrance to the humidiﬁ cation chamber 
(20, 55, and 90  L/minute). At high ﬂ ow rates, many 
commer cial humidiﬁ ers were unable to generate ade-
quate RH. Clinically, this suggests that a humidiﬁ er alone 
may not be enough to ensure adequate humidiﬁ cation of 
inspired gases, particularly at high ﬂ ow rates [26].
Types of humidifi cation system
In general, HH and HME technically produce similar AH 
levels (25 to 30  mgH2O/L), which are adequate for the 
physiological functioning of the upper airway. However, 
the gas conditioning performance of each system may 
vary over a range of respiratory rates, especially at the 
ventilator airﬂ ow that enters the system through the 
humidiﬁ cation chamber [18,27,28].
Th e choice of active HH or HME may have reper-
cussions on respiratory mechanics - such as tidal 
volume, minute volume, and work of breathing - and 
gas exchange [29,30]. For NIV, signiﬁ cant disadvantages 
have been observed with the HME compared to the HH 
(Table 2). HMEs have been associated with greater dead 
space and possibly also CO2 retention. Th is was shown 
by Jaber and colleagues [29], who reported higher 
partial pressure of arterial carbon dioxide (PaCO2) 
during NIV with HME than with HH. Similarly, 
Lellouche and colleagues [30] found inspiratory eﬀ ort 
was greater in patients with hyper capnia during HME 
than HH. Th is has also been associated with increased 
work of breathing. On the basis of these studies, 
therefore, it would seem that HH is superior to HME 
during acute NIV but this advantage is probably limited 
to acute rather than chronic settings.
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Th e choice of the humidiﬁ er for NIV must also take 
into consideration the interface, and the amount of 
unintentional leaks. In the absence of substantial leaks, 
the AH was no diﬀ erent with HH or HME when using a 
face mask during NIV [10]. However, when there were 
excessive leaks the AH signiﬁ cantly dropped when using 
HME (around 40%). Th e leak aﬀ ects the HME’s perfor-
mance by changing the diﬀ erence between inspired 
volume (cool air) and expired volume (warm, moist air).
In their bench study, Holland and colleagues [31] 
examined the eﬀ ects of mechanical ventilation para-
meters on RH and AH, and the eﬀ ect of a HH system on 
RH, AH, and ventilator performance during NIV. With-
out humidiﬁ cation, RH in the NIV circuit (range 16.3 to 
26.5%) was substantially lower than the ambient RH (27.6 
to 31.5%) at all ventilatory settings. Increasing the IPAP 
led to a signiﬁ cant decrease in RH (Spearman’s rho = 
0.67, P < 0.001), which returned to normal when HH was 
applied. Changing the respiratory rate or inspiratory-
expiratory ratio had no signiﬁ cant eﬀ ect. RH and AH 
both rose with the addition of humidiﬁ cation, and the air 
was fully saturated at the maximum heater setting. A key 
conclusion of this study was therefore that the incor-
poration of HH systems in NIV ventilators increased the 
RH.
Esquinas and colleagues [32] analyzed AH values in a 
series of patients with hypoxemic acute respiratory 
failure, with NIV administered by a turbine-driven venti-
lator and a face mask, over a wide range of inspired 
oxygen fractions in four diﬀ erent NIV environments: 1) 
without humidiﬁ cation; 2) with a HH-MR850; 3) with a 
HH730; 4) with a HME booster. Th e main ﬁ ndings were 
that the increase in inspired oxygen fraction led to a 
proportional decrease in AH and this eﬀ ect was greater 
in an environment without humidiﬁ cation than during 
NIV delivered with HH and HME-booster systems, and 
that AH levels were ‘critical’ when the inspired oxygen 
fraction was higher than 60% [32].
In agreement with Holland and colleagues [31], 
Esquinas and colleagues [32] found AH was higher with a 
humidiﬁ cation system. When HH and HME booster 
systems were compared, AH was higher with the latter; 
however, the HME booster caused more patient-venti-
lator asynchrony and hypercapnia.
Th ere is as yet no uniform recommendation for any 
one device and there is also only limited epidemiological 
information on the best hospital practices and protocols 
for humidiﬁ cation and device selection. Recently, our 
international group for the study of humidiﬁ cation (the 
Humivenis Working Group) carried out a survey in 15 
units with NIV expertise and found that usual practice 
was to use HH more often than HME for acute NIV 
applications (53% versus 6.6%). Surprisingly, despite the 
importance of gas conditioning during NIV, there were 
relatively few hospital protocols referring to humidiﬁ ca-
tion practice in the participating centers (55%) [6].
Humidifi cation and CPAP therapy in patients with 
obstructive sleep apnea
Obstructive sleep apnea (OSA) is one of the most 
important indications for chronic use of CPAP at home. 
CPAP therapy is the gold standard for OSA patients and 
compliance with therapy reduces morbidity and mortality 
[33]. Nevertheless, compliance and adherence to CPAP 
for OSA patients remains a major problem. Th e most 
frequently reported factors associated with low accep-
tance and adherence rates include side eﬀ ects such as 
nasal congestion, dry nose or throat, discomfort related 
Table 2. Advantages and disadvantages of heat and moisture exchanger fi lter and heated humidifi er systems during 
non-invasive ventilation
System Advantages Disadvantages
HME Cost eff ective
Extended use in the ICU
Eliminates circuit condensation (hygroscopic models are 
recommended)
A booster system applied to a hydrophobic HME may preserve 
AH capacity when incoming gases are delivered at a temperature 
lower than 26°C and at high fl ow
Does not need electricity
Increased dead space
Reduced effi  cacy in case of leaks
Effi  cacy depends on body and environmental temperatures
May lead to an increase in airway resistance in patients with heavy secretions 
and respiratory tract bleeding
HH Less work of breathing than with HME
Limited or no eff ect on dead space ventilation so CO2 retention is 
minimal
Achieves RH and AH values suffi  cient for gas conditioning
Clinically eff ective, especially in patients with mild to severe 
hypercapnic acute respiratory failure
Less effi  cacy with high environmental temperature
Needs electricity
Performance of diff erent devices varies
AH, absolute humidity; HH, heated humidifi er; HME, heat and moisture exchanger fi lter; RH, relative humidity.
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to cold air, and/or allergy to the interface material; these 
are reported by as many as 65% of patients using nasal 
CPAP [34]. Chronic nasal congestion in particular can 
compromise a patient’s ability to use CPAP successfully.
Th e nasal mucosa has a considerable capacity for 
heating and humidifying inspired air but even so it can be 
overwhelmed at high ﬂ ow rates with CPAP and when 
there is unidirectional ﬂ ow caused, for instance, by 
mouth leaks. Th e ﬂ ow of cold air through the nose dries 
the mucosa, resulting in the release of vasoactive and 
proinﬂ ammatory mediators. Th ese boost superﬁ cial 
mucosal blood ﬂ ow and cause engorgement of deeper 
capacitance vessels, leading to increased nasal resistance. 
Th is in turn promotes mouth breathing, setting up a 
vicious circle.
Th ese complications can be largely prevented by 
humidifying the inspired air. Most current CPAP devices 
come with an integrated HH system. As these deliver 
more moisture than cold pass-over humidiﬁ ers they may 
be more eﬀ ective in patients with mouth leak and nasal 
congestion [12].
HH reduces nasal symptoms and nasal resistance, 
consequently attenuating inﬂ ammatory cell inﬁ ltration 
and ﬁ brosis of the nasal mucosa [35,36]. Th erefore, the 
American Academy of Sleep Medicine has recommended 
the use of HH to improve CPAP compliance and adher-
ence as a standard of practice [37]. According to the 
scientiﬁ c literature, however, HH should only be added 
when patients complain of bothersome upper airway 
symptoms that are unresponsive to simpler measures (for 
example, intranasal steroids, temporary use of local vaso-
constrictors) as there is no reliable information on the 
improvements in CPAP acceptance, adherence, or quality 
of life resulting from ‘prophylactic’ humidiﬁ cation [36,38].
Conclusion
During NIV, adequate gas conditioning is essential 
because of the deleterious eﬀ ects of inhalation of dry air, 
which may then negatively inﬂ uence adherence to and 
the success of the ventilatory treatment. Several para-
meters, mostly involving the technical aspects of NIV, are 
determinants of ineﬃ  cient humidiﬁ cation. Th e correct 
application of an appropriate humidiﬁ cation system may 
help prevent NIV-induced airway dryness. However, 
there are still open questions about when exactly to apply 
a humidiﬁ er in acute or chronic settings, the best type of 
humidiﬁ cation device in each situation, the interaction 
between the humidiﬁ er and the underlying disease and 
the eﬀ ects of individual ventilators on delivered humidity.
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